Healthcare organisations should use strong, multi factor authentication for electronic prescription orders, especially where state rules require positive identification. Passwords alone are too easy to share, steal, or misuse. A practical approach combines something the prescriber knows with a stronger factor such as biometrics, a proximity badge, or another secure verifier that ties the order to an approved clinician.
Why password-only authentication is a poor fit for prescription orders
Electronic prescribing is a high-trust workflow: the system is not just proving that someone can log in, it is proving that an approved clinician is issuing a controlled medical order. Passwords alone do not give enough assurance for that decision because they are easy to reuse, share, phish, or steal, and they do not reliably bind the order to the person who is supposed to authorise it.
Healthcare organisations should therefore treat password-only access as insufficient for the act of prescribing, even if passwords remain part of the login flow. The practical goal is stronger assurance at the point of order creation, not merely a successful sign-in.
What stronger authentication should prove before a prescription is accepted
The control objective is to confirm that the prescriber is both known to the organisation and present at the time of ordering. A stronger design combines something the prescriber knows with a second factor that is harder to share or replay, such as biometrics, a secure hardware or proximity-based verifier, or a phishing-resistant authentication method that binds the action to the approved clinician session.
That distinction matters because prescription orders are action-oriented, not just account-oriented. The authentication step should reduce the chance that a stolen password, a shared credential, or an unattended session can be turned into an authorised medication order without additional proof.
For organisations building this control, the most useful comparison point is phishing-resistant identity assurance guidance from NIST SP 800-63 Digital Identity Guidelines, which help separate ordinary login from stronger authenticators fit for higher-risk transactions.
How healthcare workflows should implement that assurance without slowing care
The right pattern is to apply stronger verification where the clinical or regulatory risk is highest, rather than to force the same step on every low-risk action. Electronic prescribing often justifies step-up authentication at order submission, renewal, or any action that can create material patient safety or diversion risk.
In practice, that means choosing factors that are durable under clinical pressure. Biometrics can help when the environment supports them, but they need careful fallback and recovery handling. Hardware-backed sign-in, passkeys, or other phishing-resistant methods can be a better fit when the organisation wants less dependence on shared knowledge secrets and better resistance to remote abuse.
Healthcare teams looking for a broader implementation path can use Passwordless and Passkeys Guide to think through stronger authenticators, and MFA Guide to compare factor types and the common bypass patterns that matter in real deployments.
Risk and Threat Considerations
Prescription systems are attractive targets because a successful compromise can create unsafe orders, fraudulent activity, or delegated misuse at scale. The main exposure is not just account takeover, but the gap between “someone got into the account” and “the approved clinician actually authorised this specific prescription.”
Failure mechanism: Attackers or insiders obtain a password through phishing, reuse, theft, or sharing, then reuse that access to submit orders under a legitimate clinician identity. If the workflow relies on one factor alone, the system has little ability to distinguish a real prescribing event from a credential replay.
Impact: That failure can lead to unauthorised medication orders, compliance violations, diversion risk, and difficult forensic separation between legitimate and illegitimate prescribing activity. It also weakens accountability, because the record may appear valid even when the underlying act was not properly authorised.
For a concrete reminder of why stronger authentication matters, healthcare and other high-value environments repeatedly show that weak access control can be enough to trigger major compromise. The control lesson from Change Healthcare breach 2024 is that a single compromised login path can have outsized operational consequences when MFA is missing.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
NIST SP 800-63 and NIST SP 800-53 Rev 5 set the technical controls, while ISO/IEC 27001:2022 defines the regulatory obligations.
| Framework | Control / Reference | Relevance |
|---|---|---|
| NIST SP 800-63 | Digital Identity Guidelines | Electronic prescription ordering depends on stronger authenticator assurance. |
| Recommendation — Use higher-assurance authenticators for prescription submission and step up for higher-risk transactions. | ||
| NIST SP 800-53 Rev 5 | IA-2 — Identification and Authentication (Organizational Users) | Prescribers are organisational users whose identity must be verified before order authorisation. |
| IA-5 — Authenticator Management | Passwords alone are insufficient; lifecycle and management of authenticators matter here. | |
| IA-8 — Identification and Authentication (Non-Organizational Users) | If external clinicians or partners place orders, their authentication assurance still matters. | |
| Recommendation — Require strong organisational user authentication before allowing prescription creation. Manage authenticators so shared or weak credentials cannot be used for prescribing. Apply strong authentication to external users who can submit or approve orders. | ||
| ISO/IEC 27001:2022 | A.5.16 — Identity management | Prescription access must be tied to managed identities and approved clinician roles. |
| A.5.17 — Authentication information | Passwords and other authenticators need protection because compromise undermines order integrity. | |
| Recommendation — Maintain controlled identities for prescribing users and remove stale access promptly. Protect and rotate authentication information that can be used to submit orders. | ||
Practitioner Guidance
What to verify: Verify that the prescriber authentication method is appropriate for the prescribing action itself, not just for general portal access. If the control only proves password possession, it is not strong enough for orders that carry clinical or regulatory significance.
Decision rule: If the workflow can create a legally or clinically binding prescription, require a stronger verifier at the point of order submission, and reserve password-only access for low-risk navigation or non-sensitive account functions.
Practitioner takeaway: The important design choice is to bind the prescription to a clinician-level proof, not merely to an authenticated session. If that proof can be shared, phished, or replayed, the organisation has not really solved prescription authentication.
Related resources from NHI Mgmt Group
- How should organisations design proof-of-identity flows when employees need to access services without relying on passwords or central repositories?
- How should organisations design digital identity proofing without relying on passwords or weak second factors?
- How should healthcare organisations implement EPCS without weakening prescriber authentication or prescription integrity?
- How should organisations use liveness detection and facial biometrics to defend against deepfake attacks without over-relying on passwords or one-time codes?
Deepen Your Knowledge
Reviewed and updated by the NHIMG editorial team on September 29, 2026.
NHI Mgmt Group — the #1 independent authority on Non-Human Identity, IAM, and Agentic AI security. nhimg.org
